EVA Pharma participates in the European Association for the Study of Diabetes’ annual conference

19 Sep, 2022

EVA Pharma participates in the European Association for the Study of Diabetes’ annual conference

19 Sep, 2022


Cairo , September 19th - Representatives of EVA Pharma participated in the 58th Annual Meeting of the European Association for the Study of Diabetes (ESAD), which took place in Stockholm, Sweden, from 19 to 23 September. 

This year's conference was attended by more than 15,000 physicians from around the world, including those who attended via the conference’s virtual platforms. This figure reflects the importance of the conference for both doctors and pharmaceutical companies alike who work in the field of diabetes 

The conference included presentations and discussions about the latest research in the field, including new treatments and their complications; the correlation between diabetes, liver and kidney disease; the effect of diabetes on the feet and how to prevent diabetic foot diseases; the relationship between diabetes, heart disease and blood pressure; and ways to care for diabetics and reduce the complications associated with the disease.  

Ambassador Ahmed Adel Sobhi, Ambassador of Egypt to the Kingdom of Sweden and the Republic of Latvia, praised the participation of EVA Pharma, as a leading Egyptian company in the field of pharmaceuticals, and noted that EVA’s manufacturing of medicines to the highest international quality standards was praised by experts participating in the conference. 

For his part, Dr. George Maher, General Manager at EVA Pharma, noted that EVA has prioritized providing the best treatments for diabetes and diabetes complications to patients,” and said that the company is “intensifying its efforts in the field of scientific research and in providing the latest research and developments to support care for diabetic patients.” 

He also highlighted EVA Pharma's sponsorship of a number of different awareness campaigns targeting diabetic patients, including a campaign highlighting the importance of continuing treatment to keep the blood sugar level under control per medical guidelines, and other campaigns to raise awareness of peripheral neuropathy and the complications of diabetes, including foot amputation.

eva logo

We empower the fight for health and well being as a human right.

Subscribe for our latest news and updates

Quick Links

Follow Us

youtube yellow
© 2022 Eva Pharma All Rights Reserved - شركة ايفا فارما للادوية و المستلزمات الطبية